Focal therapy, differential therapy, and radiation treatment for prostate cancer
- PMID: 22666239
- PMCID: PMC3362011
- DOI: 10.1155/2012/573193
Focal therapy, differential therapy, and radiation treatment for prostate cancer
Abstract
Focal and differential therapy represent an approach to improve the therapeutic ratio of prostate cancer treatments. This concept is a shift from treating the whole gland to intensely treating the portion of the gland that contains significant tumor. However, there are many challenges in the move towards focal approaches. Defining which patients are suitable candidates for focal therapy approaches is an area of significant controversy, and it is likely that additional data from imaging or detailed biopsy methods is needed in addition to traditional risk factors. A number of methods have been suggested, and imaging with multiparametric MRI and transperineal template mapping biopsy have shown promise. The approach of differential therapy where the entire prostate is treated to a lower intensity and the tumor areas to high intensity is also discussed in detail. Radiation therapy is a well suited modality for the delivery of differential therapy. Data in the literature using external beam radiation, high dose rate brachytherapy, and low-dose rate brachytherapy for differential therapy are reviewed. Preliminary results are encouraging, and larger studies and randomized controlled trials are needed to validate this approach.
Similar articles
-
Focal Salvage High Dose-Rate Brachytherapy for Locally Recurrent Prostate Cancer After Primary Radiation Therapy Failure: Results From a Prospective Clinical Trial.Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):561-567. doi: 10.1016/j.ijrobp.2018.06.039. Epub 2018 Jul 2. Int J Radiat Oncol Biol Phys. 2018. PMID: 30244878 Clinical Trial.
-
Does brachytherapy have a role in the treatment of prostate cancer?Hematol Oncol Clin North Am. 1996 Jun;10(3):653-73. doi: 10.1016/s0889-8588(05)70359-2. Hematol Oncol Clin North Am. 1996. PMID: 8773503 Review.
-
Evaluating localized prostate cancer and identifying candidates for focal therapy.Urology. 2008 Dec;72(6 Suppl):S12-24. doi: 10.1016/j.urology.2008.10.004. Urology. 2008. PMID: 19095124
-
Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.Prescrire Int. 2012 Oct;21(131):242-8. Prescrire Int. 2012. PMID: 23185849 Review.
-
Extensive Histological Sampling following Focal Therapy of Clinically Significant Prostate Cancer with High Intensity Focused Ultrasound.J Urol. 2019 Oct;202(4):717-724. doi: 10.1097/JU.0000000000000298. Epub 2019 Sep 6. J Urol. 2019. PMID: 31042109 Clinical Trial.
Cited by
-
Focal therapy in prostate cancer: the current situation.Ecancermedicalscience. 2014 Jun 10;8:435. doi: 10.3332/ecancer.2014.435. eCollection 2014. Ecancermedicalscience. 2014. PMID: 24944577 Free PMC article. Review.
-
A deformable multimodal image registration using PET/CT and TRUS for intraoperative focal prostate brachytherapy.Proc SPIE Int Soc Opt Eng. 2019 Feb;10951:109511I. doi: 10.1117/12.2512996. Epub 2019 Mar 8. Proc SPIE Int Soc Opt Eng. 2019. PMID: 32341619 Free PMC article.
-
Recent developments and best practice in brachytherapy treatment planning.Br J Radiol. 2014 Sep;87(1041):20140146. doi: 10.1259/bjr.20140146. Epub 2014 Jun 2. Br J Radiol. 2014. PMID: 24734939 Free PMC article. Review.
-
Assessing high-intensity focused ultrasound treatment of prostate cancer with hyperpolarized 13 C dual-agent imaging of metabolism and perfusion.NMR Biomed. 2019 Oct;32(10):e3962. doi: 10.1002/nbm.3962. Epub 2018 Jul 18. NMR Biomed. 2019. PMID: 30022550 Free PMC article.
-
Deformable registration of PET/CT and ultrasound for disease-targeted focal prostate brachytherapy.J Med Imaging (Bellingham). 2019 Jul;6(3):035003. doi: 10.1117/1.JMI.6.3.035003. Epub 2019 Sep 12. J Med Imaging (Bellingham). 2019. PMID: 31528661 Free PMC article.
References
-
- American Cancer Society. Cancer Facts and Figures 2012. 2012.
-
- Alicikus ZA, Yamada Y, Zhang Z, et al. Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer. Cancer. 2011;117(7):1429–1437. - PubMed
LinkOut - more resources
Full Text Sources